Cargando…
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
OBJECTIVE: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. STUDY DESIGN: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...
Autores principales: | Schwebke, Jane R., Carter, Belvia A., Waldbaum, Arthur S., Agnew, Kathy J., Paull, Jeremy R.A., Price, Clare F., Castellarnau, Alex, McCloud, Philip, Kinghorn, George R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843408/ https://www.ncbi.nlm.nih.gov/pubmed/33537666 http://dx.doi.org/10.1016/j.eurox.2021.100121 |
Ejemplares similares
-
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
por: Waldbaum, Arthur S., et al.
Publicado: (2020) -
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
por: Castellarnau, Alex, et al.
Publicado: (2022) -
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
por: Paull, Jeremy R.A., et al.
Publicado: (2021) -
Astodrimer sodium and bacterial vaginosis: a mini review
por: Mendling, Werner, et al.
Publicado: (2022) -
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
por: Paull, Jeremy R. A., et al.
Publicado: (2021)